These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 4608303)

  • 1. Physicochemical properties, development, and regulation of central and peripheral monoamine oxidase activity.
    Youdim MB; Holzbauer M; Woods HF
    Adv Biochem Psychopharmacol; 1974; 12(0):11-28. PubMed ID: 4608303
    [No Abstract]   [Full Text] [Related]  

  • 2. Some considerations in the design of substrate and tissue-specific inhibitors of monoamine oxidase.
    Martin YC; Biel JH
    Adv Biochem Psychopharmacol; 1974; 12(0):37-48. PubMed ID: 4417042
    [No Abstract]   [Full Text] [Related]  

  • 3. The use of selective monoamine oxidase inhibitor drugs to modify amine metabolism in brain.
    Neff NH; Yang HY; Fuentes JA
    Adv Biochem Psychopharmacol; 1974; 12(0):49-57. PubMed ID: 4609330
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver.
    Ozaita A; Olmos G; Boronat MA; Lizcano JM; Unzeta M; García-Sevilla JA
    Br J Pharmacol; 1997 Jul; 121(5):901-12. PubMed ID: 9222546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the dual nature of monoamine oxidase.
    Knoll J
    Horiz Biochem Biophys; 1978; 5():37-64. PubMed ID: 355087
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical chemistry of monoamine oxidase.
    Glover V; Sandler M
    Cell Biochem Funct; 1986 Apr; 4(2):89-97. PubMed ID: 3486724
    [No Abstract]   [Full Text] [Related]  

  • 7. N-substituted cyclopropylamines as monoamine oxidase inhibitors. Structure-activity relationships. Dopa potentiation in mice and in vitro inhibition of kynuramine oxidation.
    Mills J; Kattau R; Slater IH; Fuller RW
    J Med Chem; 1968 Jan; 11(1):95-7. PubMed ID: 4384132
    [No Abstract]   [Full Text] [Related]  

  • 8. Proceedings: Influence of endocrine glands on central and peripheral monoamine oxidase activity.
    Holzbauer M; Youdim MB
    Br J Pharmacol; 1972 Feb; 44(2):355P-356P. PubMed ID: 4677509
    [No Abstract]   [Full Text] [Related]  

  • 9. Kinetic studies and effects in vivo of a new monoamine oxidase inhibitor, N-[2-(o-chlorophenoxy)-ethyl]-cyclopropylamine.
    Fuller RW
    Biochem Pharmacol; 1968 Oct; 17(10):2097-106. PubMed ID: 5696879
    [No Abstract]   [Full Text] [Related]  

  • 10. [Multiplicity of mitochondrial monoamine exidases and ways of selective blocking of the enzyme activity].
    Severina IS
    Biokhimiia; 1976 Jul; 41(6):955-67. PubMed ID: 829219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and characterization of a monoamine oxidase B selective inhibitor from tobacco smoke.
    Khalil AA; Davies B; Castagnoli N
    Bioorg Med Chem; 2006 May; 14(10):3392-8. PubMed ID: 16458520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of a novel class of potent coumarin monoamine oxidase B inhibitors: development and biopharmacological profiling of 7-[(3-chlorobenzyl)oxy]-4-[(methylamino)methyl]-2H-chromen-2-one methanesulfonate (NW-1772) as a highly potent, selective, reversible, and orally active monoamine oxidase B inhibitor.
    Pisani L; Muncipinto G; Miscioscia TF; Nicolotti O; Leonetti F; Catto M; Caccia C; Salvati P; Soto-Otero R; Mendez-Alvarez E; Passeleu C; Carotti A
    J Med Chem; 2009 Nov; 52(21):6685-706. PubMed ID: 19810674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The labeling in vivo of monoamine oxidase by 14 C-pargyline: a tool for studying the synthesis of the enzyme.
    Erwin VG; Deitrich RA
    Mol Pharmacol; 1971 Mar; 7(2):219-28. PubMed ID: 5125856
    [No Abstract]   [Full Text] [Related]  

  • 14. Some kinetic and inhibition properties of human brain mitochondrial monoamine oxidase (EC 1.4.3.4).
    Jain M; Bakutis E; Gayle T; Lansky P
    Neurobiology; 1974; 4(3):180-90. PubMed ID: 4367441
    [No Abstract]   [Full Text] [Related]  

  • 15. Kinetic studies on rat brain monoamine oxidase.
    Huszti Z
    Mol Pharmacol; 1972 Jul; 8(4):385-97. PubMed ID: 5053580
    [No Abstract]   [Full Text] [Related]  

  • 16. Endometrial monoamine oxidase: the effect of sex steroids.
    Southgate J
    Adv Biochem Psychopharmacol; 1972; 5():263-9. PubMed ID: 4559888
    [No Abstract]   [Full Text] [Related]  

  • 17. [Mitochondrial monoamine oxidase in the brain, stomach and liver in experimental gastric ulcer and the change in their activity under the influence of quateron].
    Virabian TL
    Zh Eksp Klin Med; 1976; 16(5):11-9. PubMed ID: 1023702
    [No Abstract]   [Full Text] [Related]  

  • 18. The monoamine oxidase inhibitory effect of new homopyrimidazole derivatives.
    Magyar K; Satory E; Meszaros Z
    Med Biol; 1974 Dec; 52(6):384-9. PubMed ID: 4444359
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparative study of catalytic properties of mink and rat liver monoamine oxidase].
    Iagodina OV
    Zh Evol Biokhim Fiziol; 2008; 44(6):570-6. PubMed ID: 19198157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzymology of monoamine oxidase.
    Tipton KF
    Cell Biochem Funct; 1986 Apr; 4(2):79-87. PubMed ID: 3518979
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.